Biofil Common Stock Shares Outstanding vs Net Tangible Assets Analysis

BIOFILCHEM

49.34 1.63 3.20%

Biofil Chemicals financial indicator trend analysis is way more than just evaluating Biofil Chemicals Pha prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofil Chemicals Pha is a good investment. Please check the relationship between Biofil Chemicals Common Stock Shares Outstanding and its Net Tangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Common Stock Shares Outstanding vs Net Tangible Assets

Common Stock Shares Outstanding vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofil Chemicals Pha Common Stock Shares Outstanding account and Net Tangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Biofil Chemicals' Common Stock Shares Outstanding and Net Tangible Assets is -0.35. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Biofil Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Biofil Chemicals' Common Stock Shares Outstanding and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Biofil Chemicals Pharmaceuticals are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Common Stock Shares Outstanding i.e., Biofil Chemicals' Common Stock Shares Outstanding and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

-0.35

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most indicators from Biofil Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofil Chemicals Pha current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

The current year's Selling General Administrative is expected to grow to about 8.1 M. The current year's Tax Provision is expected to grow to about 2.4 M

	2022	2023	2024	2025 (projected)
Interest Expense	425K	415K	373.5K	354.8K
Depreciation And Amortization	4.3M	4.0M	4.6M	3.1M

Interest Expense Depreciation And Amortization

Biofil Chemicals fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Current Deferred Revenue	Other Liab	Net Tangible Assets
Common Stock Shares Outstanding		-0.34	0.71	-0.37	-0.3	-0.59	-0.77	0.58	-0.27	-0.26	-0.17	-0.65	0.04	-0.17	-0.32	0.99	-0.25	-0.5	-0.13	-0.19	-0.32	-0.93	-0.04	0.03	-0.26	-0.35
Total Assets	-0.34		-0.75	0.62	0.98	0.72	0.5	-0.89	0.32	0.98	0.84	0.53	-0.18	0.85	1.0	-0.26	0.79	0.09	-0.11	0.97	1.0	0.54	-0.7	-0.16	0.79	0.76
Short Long Term Debt Total	0.71	-0.75		-0.36	-0.63	-0.92	-0.66	0.93	-0.57	-0.64	-0.49	-0.62	0.02	-0.49	-0.74	0.62	-0.69	-0.27	0.3	-0.57	-0.74	-0.75	0.68	0.07	-0.75	-0.86
Other Current Liab	-0.37	0.62	-0.36		0.63	0.43	0.63	-0.47	-0.02	0.6	0.53	0.66	-0.62	0.53	0.6	-0.35	0.46	0.29	0.11	0.6	0.6	0.48	-0.11	-0.44	0.57	0.38
Total Current Liabilities	-0.3	0.98	-0.63	0.63		0.6	0.46	-0.81	0.19	1.0	0.84	0.49	-0.19	0.84	0.98	-0.24	0.72	0.06	0.01	0.99	0.98	0.5	-0.57	-0.19	0.68	0.62
Total Stockholder Equity	-0.59	0.72	-0.92	0.43	0.6		0.59	-0.87	0.62	0.6	0.46	0.56	-0.14	0.46	0.71	-0.49	0.67	0.26	-0.28	0.55	0.71	0.68	-0.69	-0.14	0.77	0.95
Property Plant And Equipment Net	-0.77	0.5	-0.66	0.63	0.46	0.59		-0.56	0.13	0.42	0.23	0.99	-0.43	0.23	0.46	-0.76	0.48	0.27	-0.19	0.38	0.47	0.8	-0.13	-0.49	0.52	0.47
Net Debt	0.58	-0.89	0.93	-0.47	-0.81	-0.87	-0.56		-0.42	-0.81	-0.77	-0.53	0.0	-0.77	-0.87	0.49	-0.77	-0.19	0.1	-0.76	-0.89	-0.71	0.7	-0.01	-0.78	-0.84
Retained Earnings	-0.27	0.32	-0.57	-0.02	0.19	0.62	0.13	-0.42		0.22	0.0	0.09	-0.1	0.0	0.34	-0.19	0.29	0.14	-0.29	0.18	0.32	0.22	-0.56	-0.01	0.54	0.63
Accounts Payable	-0.26	0.98	-0.64	0.6	1.0	0.6	0.42	-0.81	0.22		0.84	0.47	-0.19	0.84	0.98	-0.19	0.74	0.03	-0.04	1.0	0.98	0.46	-0.63	-0.19	0.71	0.65
Cash	-0.17	0.84	-0.49	0.53	0.84	0.46	0.23	-0.77	0.0	0.84		0.27	0.02	1.0	0.83	-0.09	0.64	0.01	0.24	0.85	0.85	0.43	-0.5	0.14	0.58	0.51
Non Current Assets Total	-0.65	0.53	-0.62	0.66	0.49	0.56	0.99	-0.53	0.09	0.47	0.27		-0.5	0.27	0.5	-0.64	0.52	0.19	-0.24	0.43	0.5	0.72	-0.19	-0.56	0.57	0.48
Non Currrent Assets Other	0.04	-0.18	0.02	-0.62	-0.19	-0.14	-0.43	0.0	-0.1	-0.19	0.02	-0.5		0.02	-0.16	0.04	-0.25	0.23	0.08	-0.19	-0.16	-0.03	-0.01	0.78	-0.44	-0.17
Cash And Short Term Investments	-0.17	0.85	-0.49	0.53	0.84	0.46	0.23	-0.77	0.0	0.84	1.0	0.27	0.02		0.83	-0.09	0.64	0.01	0.24	0.85	0.85	0.43	-0.5	0.14	0.58	0.51
Net Receivables	-0.32	1.0	-0.74	0.6	0.98	0.71	0.46	-0.87	0.34	0.98	0.83	0.5	-0.16	0.83		-0.24	0.75	0.11	-0.11	0.97	1.0	0.52	-0.7	-0.16	0.78	0.75
Non Current Liabilities Total	0.99	-0.26	0.62	-0.35	-0.24	-0.49	-0.76	0.49	-0.19	-0.19	-0.09	-0.64	0.04	-0.09	-0.24		-0.14	-0.52	-0.14	-0.13	-0.24	-0.89	-0.16	0.06	-0.15	-0.23
Inventory	-0.25	0.79	-0.69	0.46	0.72	0.67	0.48	-0.77	0.29	0.74	0.64	0.52	-0.25	0.64	0.75	-0.14		-0.28	-0.2	0.72	0.79	0.39	-0.7	-0.23	0.8	0.74
Other Current Assets	-0.5	0.09	-0.27	0.29	0.06	0.26	0.27	-0.19	0.14	0.03	0.01	0.19	0.23	0.01	0.11	-0.52	-0.28		0.05	0.0	0.08	0.46	0.13	0.19	-0.03	0.09
Other Stockholder Equity	-0.13	-0.11	0.3	0.11	0.01	-0.28	-0.19	0.1	-0.29	-0.04	0.24	-0.24	0.08	0.24	-0.11	-0.14	-0.2	0.05		-0.01	-0.1	0.19	0.54	0.38	-0.27	-0.42
Total Liab	-0.19	0.97	-0.57	0.6	0.99	0.55	0.38	-0.76	0.18	1.0	0.85	0.43	-0.19	0.85	0.97	-0.13	0.72	0.0	-0.01		0.97	0.41	-0.6	-0.19	0.68	0.61
Total Current Assets	-0.32	1.0	-0.74	0.6	0.98	0.71	0.47	-0.89	0.32	0.98	0.85	0.5	-0.16	0.85	1.0	-0.24	0.79	0.08	-0.1	0.97		0.53	-0.7	-0.14	0.79	0.76
Common Stock	-0.93	0.54	-0.75	0.48	0.5	0.68	0.8	-0.71	0.22	0.46	0.43	0.72	-0.03	0.43	0.52	-0.89	0.39	0.46	0.19	0.41	0.53		-0.1	0.01	0.4	0.48
Short Term Debt	-0.04	-0.7	0.68	-0.11	-0.57	-0.69	-0.13	0.7	-0.56	-0.63	-0.5	-0.19	-0.01	-0.5	-0.7	-0.16	-0.7	0.13	0.54	-0.6	-0.7	-0.1		0.05	-0.79	-0.86
Current Deferred Revenue	0.03	-0.16	0.07	-0.44	-0.19	-0.14	-0.49	-0.01	-0.01	-0.19	0.14	-0.56	0.78	0.14	-0.16	0.06	-0.23	0.19	0.38	-0.19	-0.14	0.01	0.05		-0.33	-0.16
Other Liab	-0.26	0.79	-0.75	0.57	0.68	0.77	0.52	-0.78	0.54	0.71	0.58	0.57	-0.44	0.58	0.78	-0.15	0.8	-0.03	-0.27	0.68	0.79	0.4	-0.79	-0.33		0.86
Net Tangible Assets	-0.35	0.76	-0.86	0.38	0.62	0.95	0.47	-0.84	0.63	0.65	0.51	0.48	-0.17	0.51	0.75	-0.23	0.74	0.09	-0.42	0.61	0.76	0.48	-0.86	-0.16	0.86

Click cells to compare fundamentals

Biofil Chemicals Account Relationship Matchups

Biofil Chemicals fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	332.4M	187.3M	314.1M	470.8M	541.5M	568.5M
Short Long Term Debt Total	4.3M	4.6M	5.2M	4.4M	4.0M	3.8M
Other Current Liab	1.4M	1.6M	933K	2.9M	3.3M	3.5M
Total Current Liabilities	167.5M	14.9M	137.3M	285.2M	328.0M	344.4M
Total Stockholder Equity	161.3M	168.4M	173.0M	182.0M	209.3M	119.5M
Property Plant And Equipment Net	97.8M	94.2M	90.0M	86.2M	99.2M	99.3M
Net Debt	(107K)	3.2M	5.0M	(18.4M)	(16.6M)	(15.8M)
Retained Earnings	(337.7M)	(330.6M)	(128.5M)	(316.9M)	(364.5M)	(382.7M)
Accounts Payable	158.5M	6.0M	126.5M	275.5M	316.9M	332.7M
Cash	4.4M	1.5M	260K	22.8M	26.3M	27.6M
Non Current Assets Total	97.8M	94.2M	90.0M	86.8M	99.8M	99.9M
Non Currrent Assets Other	(37K)	(191K)	(307K)	508K	457.2K	480.1K
Cash And Short Term Investments	4.4M	1.5M	377K	22.8M	26.3M	27.6M
Net Receivables	186.0M	71.8M	205.0M	330.3M	379.8M	398.8M
Liabilities And Stockholders Equity	332.4M	187.3M	314.1M	470.8M	541.5M	568.5M
Non Current Liabilities Total	3.6M	4.0M	3.8M	3.6M	3.2M	3.0M
Inventory	43.4M	12.9M	12.1M	25.5M	29.3M	30.8M
Other Current Assets	793K	7.0M	6.5M	5.5M	6.3M	5.4M
Total Liab	171.1M	18.9M	141.0M	288.8M	332.1M	348.7M
Total Current Assets	234.6M	93.1M	224.1M	384.1M	441.7M	463.8M
Short Term Debt	4.3M	4.6M	2.9M	4.4M	4.0M	3.8M
Current Deferred Revenue	(4.3M)	4.3M	2.3M	1.4M	1.7M	1.7M
Net Tangible Assets	136.5M	148.8M	161.3M	168.4M	193.6M	140.0M
Short Long Term Debt	4.3M	4.6M	5.2M	4.4M	4.0M	3.8M
Property Plant Equipment	100.9M	97.8M	94.2M	90.0M	103.5M	103.6M
Net Invested Capital	165.6M	173.0M	178.2M	186.4M	214.4M	182.9M
Cash And Equivalents	2.6M	4.4M	1.4M	260K	234K	222.3K
Net Working Capital	67.1M	78.2M	86.8M	98.8M	113.7M	71.0M
Property Plant And Equipment Gross	115.5M	116.2M	116.3M	116.5M	134.0M	127.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Other Information on Investing in Biofil Stock

Balance Sheet is a snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Biofil Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofil Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofil currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofil Common Stock Shares Outstanding vs Net Tangible Assets Analysis

Common Stock Shares Outstanding vs Net Tangible Assets

Common Stock Shares Outstanding vs Net Tangible Assets Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Net Tangible Assets

Biofil Chemicals fundamental ratios Correlations

Biofil Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofil Chemicals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Biofil Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Accounts Payable
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Net Receivables

Common Stock	- 0.93	Common Stock Shares Outstanding
Total Stockholder Equity	- 0.92	Short Long Term Debt Total
Common Stock	- 0.89	Non Current Liabilities Total
Total Current Assets	- 0.89	Net Debt
Net Debt	- 0.89	Total Assets
Net Receivables	- 0.87	Net Debt